| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C0018736> <https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C0036667> <https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C0036668> <https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C0037791> <https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34888282_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Division of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.\', \'Division of Infectious Diseases, Brigham and Women\'s Hospital, Boston, MA, United States.\', \'Rollins School of Public Health, Emory University, Atlanta, GA, United States.\', \'Division of Infectious Diseases, Emory University, Atlanta, GA, United States.\', \'Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.\', \'Division of Infectious, Diseases, Department of Pediatrics, Emory University, Atlanta, GA, United States.\', \'Department of Anthropology, Emory University, Atlanta, GA, United States.\', \'Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, United States.\', \'Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.\', \'Emerging Infectious Diseases and Tropical Medicine Research Group, Sci-Help, Pereira, Colombia.\', \'Master of Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru.\', \'Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.\', \'Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, GA, United States.\', \'Georgia Emerging Infections Program, Atlanta, GA, United States.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Cardona-Ospina_Jaime_A> <https://research.tib.eu/covid-19/entity/Collins_Matthew_H> <https://research.tib.eu/covid-19/entity/Edupuganti_Neena> <https://research.tib.eu/covid-19/entity/Edupuganti_Srilatha> <https://research.tib.eu/covid-19/entity/Espinoza_Daniel> <https://research.tib.eu/covid-19/entity/Fairley_Jessica_K> <https://research.tib.eu/covid-19/entity/Fridkin_Scott> <https://research.tib.eu/covid-19/entity/Hammond_Skyler> <https://research.tib.eu/covid-19/entity/Heaney_Christopher_D> <https://research.tib.eu/covid-19/entity/Howard-Anderson_Jessica> <https://research.tib.eu/covid-19/entity/Kleinhenz_Jennifer> <https://research.tib.eu/covid-19/entity/Landay_Taylor> <https://research.tib.eu/covid-19/entity/Pisanic_Nora> <https://research.tib.eu/covid-19/entity/Premkumar_Lakshmanane> <https://research.tib.eu/covid-19/entity/Rodriguez-Morales_Alfonso_J> <https://research.tib.eu/covid-19/entity/Rouphael_Nadine> <https://research.tib.eu/covid-19/entity/Scherer_Erin_M> <https://research.tib.eu/covid-19/entity/Shen_Huifeng> <https://research.tib.eu/covid-19/entity/Sherman_Amy_C> <https://research.tib.eu/covid-19/entity/Simon_Trevor_W> <https://research.tib.eu/covid-19/entity/Smith_Teresa> <https://research.tib.eu/covid-19/entity/Taibl_Kaitlin> <https://research.tib.eu/covid-19/entity/Tarleton_Rick> <https://research.tib.eu/covid-19/entity/Wrammert_Jens> <https://research.tib.eu/covid-19/entity/Zhu_Yerun>
?:doi	10.3389/fpubh.2021.744535
?:doi	<https://research.tib.eu/covid-19/entity/10.3389/fpubh.2021.744535>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_N.I.H.%2C_Extramural>
?:journal	Frontiers in public health
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34888282>
?:pmid	<https://research.tib.eu/covid-19/entity/34888282>
?:pmid	34888282
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.769
?:rankingScore_hIndex	23
?:title	Application of SARS-CoV-2 Serology to Address Public Health Priorities.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Division of Infectious Diseases, The Hope Clinic of the Emory Vaccine Center, Emory University, Atlanta, GA, United States.\', \'Division of Infectious Diseases, Brigham and Women\'s Hospital, Boston, MA, United States.\', \'Rollins School of Public Health, Emory University, Atlanta, GA, United States.\', \'Division of Infectious Diseases, Emory University, Atlanta, GA, United States.\', \'Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.\', \'Division of Infectious, Diseases, Department of Pediatrics, Emory University, Atlanta, GA, United States.\', \'Department of Anthropology, Emory University, Atlanta, GA, United States.\', \'Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA, United States.\', \'Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.\', \'Emerging Infectious Diseases and Tropical Medicine Research Group, Sci-Help, Pereira, Colombia.\', \'Master of Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru.\', \'Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, United States.\', \'Emory Vaccine Center, Yerkes National Primate Research Center, Atlanta, GA, United States.\', \'Georgia Emerging Infections Program, Atlanta, GA, United States.\']

?:citedBy